Parnassus Investments
BMY icon

Parnassus Investments’s Bristol-Myers Squibb BMY Stock Holding History

Parnassus Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,900,000
Closed -$98.8M – 88
2018
Q4 		$98.8M Sell
1,900,000
-1,600,000
-46% -$86M 0.43% 56
2018
Q3 		$217M Sell
3,500,000
-100,000
-3% -$5.93M 0.83% 43
2018
Q2 		$199M Buy
3,600,000
+100,000
+3% +$5.4M 0.79% 42
2018
Q1 		$221M Buy
3,500,000
+700,000
+25% +$45M 0.89% 40
2017
Q4 		$172M Buy
2,800,000
+100,000
+4% +$6.25M 0.67% 46
2017
Q3 		$172M Buy
+2,700,000
New +$158M 0.71% 44

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Parnassus Investments's BMY Position: Q1 2019 in Review

Parnassus Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 1,900,000 shares — an estimated $98.8M sold.

Parnassus Investments first reported a position in BMY in Q3 2017 and held it in 6 quarters. The position peaked at $221M in Q1 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Parnassus Investments reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Parnassus Investments sold 1,900,000 Bristol-Myers Squibb shares in Q1 2019, an estimated $98.8M.
  • Parnassus Investments first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 6 quarters.
  • Parnassus Investments's Bristol-Myers Squibb position peaked at $221M in Q1 2018.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Parnassus Investments's 13F filing for Q1 2019, filed 1 May 2019.